Outsourced Pharma

WEBINAR: In this discussion on July 30th, discover CASP technologies - the award-winning AI and vast data that propel Lonza’s leading predictive retrosynthesis technology, used to mitigate the impact of rising small mol API complexity and its resulting longer syntheses. 📅 Reserve your spot: https://lnkd.in/eyfQtREU 🗣 Speakers: Simon Wagschal, Associate Director, Advanced Chemistry Technologies, Global R&D Small Molecules, Lonza Juergen Swienty-Busch, Director Product Management Chemistry, Elsevier

Join Mycenax Biotech Inc. CEO Pei-Jiun Chen, Ph.D at the Outsourced Pharma Fill/Finish Capacity Update, where she will share Mycenax's integrated, phase-appropriate services for drug product development and manufacturing, from formulation development to primary packaging, for mAbs, bi-specific/multi-specific antibodies, enzymes, and recombinant proteins. Register here for the July 22nd event: https://lnkd.in/e58D2Q7C

Attend Outsourced Pharma's Cell & Gene Therapy Capacity Update on July 25th, where Jonas Mortensen, CCO, will showcase Cellistic's unique capabilities for the design and optimization of proprietary manufacturing platforms for iPSC- based cell therapies. Register today for the virtual expo: https://lnkd.in/ec3SVfNR

Learn more about Alcami Corporation's oral solid dose development, solid state characterization, clinical manufacturing, batch scale up, and commercial manufacturing during Tyler Ewald, MBA's Small Molecule Capacity Update presentation on July 24th! Reserve your spot: https://lnkd.in/e7EydTrr

Join Steve Lavezoli, Vice President of Biologics, at Outsourced Pharma's Large Molecule Capacity Update on July 23rd to learn how Curia Biologics can be a critical partner for your biotech business to support all requirements from IND enabling through late stage commercial programs. Register today: https://lnkd.in/eVqJVP5f

In Singota Solutions' Fill/Finish Capacity Update presentation, Ryan Memmer will showcase their capabilities within the pharmaceutical, animal health, and biotechnology industries as they move their client’s customized high-quality products through the drug development pipeline. Reserve your spot for the July 22nd event: https://lnkd.in/e73RJF-Q

Learn more about BioCentriq's cell therapy capabilities and manufacturing capacity during Chathuranga De Silva Ph.D.'s presentation at the Outsourced Pharma Cell & Gene Therapy Capacity Update on July 25th! Register today: https://lnkd.in/eMPF-YdP

Attend Outsourced Pharma's Small Molecule Capacity Update, where Jeff Tremain will showcase AbbVie CMO and their extensive capabilities, including HPAPI & API, with a particular focus on their Campoverdi, Italy facility which currently has capacity available for near-term projects. Reserve your spot for the event on July 24th: https://lnkd.in/eANA5p-7

Watch Marty Henehan and Łukasz Waszak showcase Mabion S.A.'s new depyrogenation, fill finish vial capabilities and CMC analytical proficiencies during their Fill/Finish Capacity Update presentation on July 22nd. Register today: https://lnkd.in/eiRx9ubH

Cytovance Biologics will make their first appearance at the Outsourced Pharma Large Molecule Capacity Update on July 23rd! Axel Schleyer, Ph.D., MBA, CCO, and Brent Van Rite, Sr. Director of Manufacturing, are excited to share the company’s microbial and mammalian capabilities as well as their available capacity. Reserve your spot for the event: https://lnkd.in/edjDQ3-5